Potential therapeutic use of melatonin in migraine and other headache disorders

  title={Potential therapeutic use of melatonin in migraine and other headache disorders},
  author={M{\'a}rio Fernando Prieto Peres and Marcelo Rodrigues Masruha and Eliova Zukerman and Carlos Alberto Moreira-Filho and Esper Abr{\~a}o Cavalheiro},
  journal={Expert Opinion on Investigational Drugs},
  pages={367 - 375}
There is increasing evidence that headache disorders are connected with melatonin secretion and pineal function. Some headaches have a clearcut seasonal and circadian pattern, such as cluster and hypnic headaches. Melatonin levels have been found to be decreased in both migraine and cluster headaches. Melatonin mechanisms are related to headache pathophysiology in many ways, including its anti-inflammatory effect, toxic free radical scavenging, reduction of pro-inflammatory cytokine… 
Melatonin in headache disorders
The literature of headache is convergent in pointing to low levels of melatonin in patients with migraine and cluster headache, and treatment of headache disorders with melatonin and other chronobiotic agents is promising.
Melatonin in Chronic Pain Syndromes
The present paper reviews the studies on melatonin use in fibromyalgia, headaches, irritable bowel syndrome, chronic back pain, and rheumatoid arthritis and discusses the possible mechanisms of melatonin analgesic properties.
Therapeutic role of melatonin in migraine prophylaxis
Current literature examining melatonin's efficacy in migraine prevention is growing, but still limited, and melatonin is very likely to benefit migraine in prophylaxis and may have a similar effectiveness to other main preventive medications.
Headache endocrinological aspects.
Melatonin as a Potential Prophylactic Therapy for Menstrual-Related Migraine Headache: A Randomized Clinical Trial
The beneficial role of melatonin was shown in reducing the attack frequency and severity in migraine patients with menstrual-related headaches and preventive therapy with melatonin showed a significant reduction in the number of sedative drug use during attacks and improved the patients’ sleep quality.
A possible new option for migraine management: agomelatine.
Agomelatine may be a promising new treatment option for migraine prophylaxis due to its synergistic action on both melatonergic and 5-HT2C receptors.
Melatonin secretion in migraine patients: the current state of knowledge.
  • D. Zielonka
  • Medicine, Psychology
    Neurologia i neurochirurgia polska
  • 2021
INTRODUCTION Zduńska et al. [1] present the results of a pilot study exploring changes in melatonin serum concentration in migraine patients, and the clinical implications of these changes.
Future trends in drugs for migraine prophylaxis
Drugs designed to inhibit cortical spreading depression, for example tonabersat, might offer a useful option for the management of migraine with aura but not for migraine without aura, and inducible nitric-oxide synthase inhibition seems ineffective as a prophylactic strategy.


Melatonin, 3 mg, is effective for migraine prevention
An open-label trial of melatonin, 3 mg, for migraine prevention was performed and the hypothesis of the potential effectiveness ofmelatonin for migraine prophylaxis was tested.
Pineal opioid receptors and analgesic action of melatonin
It is believed that melatonin, with its sedative and analgesic effects, is capable of providing a pain free sleep so that the body may recuperate and restore itself to function again at its peak capacity.
The influence of the pineal gland on migraine and cluster headaches and effects of treatment with picoTesla magnetic fields.
  • R. Sandyk
  • Medicine, Psychology
    The International journal of neuroscience
  • 1992
It is proposed that the pineal gland is a critical mediator in the pathogenesis of migraine and cluster headache, and provides a framework for future research and development of new therapeutic modalities for these chronic headache syndromes.
Melatonin as Adjunctive Therapy in the Prophylaxis of Cluster Headache: A Pilot Study
The secretion of melatonin, a hormone produced by the pineal gland and regulated by the suprachiasmatic nucleus, is altered in patients with cluster headache and it is found that melatonin shifts circadian rhythms.
Melatonin in the Preventive Treatment of Chronic Cluster Headache
  • M. Peres, T. Rozen
  • Medicine, Psychology
    Cephalalgia : an international journal of headache
  • 2001
It is demonstrated that melatonin could rapidly alleviate cluster attacks, but only in episodic cluster patients, and reported two chronic cluster headache patients who had both daytime and nocturnal attacks that were alleviated with melatonin.
Melatonin Versus Placebo in the Prophylaxis of Cluster Headache
Although the response rate is low, melatonin may be suitable for cluster headache prophylaxis in some patients, particularly those who cannot tolerate other drugs.
Hypothalamic involvement in chronic migraine
Results support hypothalamic involvement in CM, shown by a chronobiologic dysregulation, and a possible hyperdopaminergic state in patients with CM, which might be an important variable in the study findings.
Melatonin–Dopamine Interactions: From Basic Neurochemistry to a Clinical Setting
  • N. Zisapel
  • Biology, Psychology
    Cellular and Molecular Neurobiology
  • 2004
The interaction of melatonin with the dopaminergic system may play a significant role in the nonphotic and photic entrainment of the biological clock as well as in the fine-tuning of motor coordination in the striatum and the antioxidant nature ofmelatonin may be beneficial in the treatment of dopamine-related disorders.
Dopamine and migraine
This review summarizes a growing body of biological, pharmacologic, and genetic data that support a role for dopamine in the pathophysiology of certain subtypes of migraine and suggests modulation of dopaminergic neurotransmission should be considered in the therapeutic management of migraine.
Advances in understanding the pathophysiology of headache.
: Recent evidence suggests that migraine may not be due to vasoconstriction followed by reactive vasodilation, and tension-type headache may not be due to excess muscle contraction. The prodromes of